SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Da-Peng Li, Chen Du, Zuo-Ming Zhang, Guang-Xiao Li, Zhi-Fu Yu, Xin Wang, Peng-Fei Li, Cheng Cheng, Yu-Peng Liu, Ya-Shuang Zhao, Breastfeeding and Ovarian Cancer Risk: a Systematic Review and Meta-analysis of 40 Epidemiological Studies, Asian Pacific Journal of Cancer Prevention, 2014, 15, 12, 4829

    CrossRef

  2. 2
    Hyun Hee Kim, Hyeong Cheol Park, Gyesik Min, Fulvestrant Does Not Have Antagonistic Effect on 17β-estradiol's Anti-proliferative Action in Cultured Chinese Hamster Ovarian Cell Line, Journal of Life Science, 2014, 24, 2, 173

    CrossRef

  3. 3
    Li-Yuan Han, Kui Liu, Xia-Lu Lin, Bao-Bo Zou, Jin-Shun Zhao, Lack of Any Association of GST Genetic Polymorphisms with Susceptibility to Ovarian Cancer - a Meta-analysis, Asian Pacific Journal of Cancer Prevention, 2014, 15, 15, 6131

    CrossRef

  4. 4
    Ana Babic, Daniel W. Cramer, Linda J. Titus, Shelley S. Tworoger, Kathryn L. Terry, Menstrual pain and epithelial ovarian cancer risk, Cancer Causes & Control, 2014, 25, 12, 1725

    CrossRef

  5. 5
    S. Jervis, H. Song, A. Lee, E. Dicks, J. Tyrer, P. Harrington, D. F. Easton, I. J. Jacobs, P. P. D. Pharoah, A. C. Antoniou, Ovarian cancer familial relative risks by tumour subtypes and by known ovarian cancer genetic susceptibility variants, Journal of Medical Genetics, 2014, 51, 2, 108

    CrossRef

  6. 6
    Asuka Morikawa, Kazu Ueda, Kazuaki Takahashi, Masaharu Fukunaga, Mitsutoshi Iwashita, Yoichi Kobayashi, Kimihiro Takechi, Satoshi Umezawa, Fumitoshi Terauchi, Kazushige Kiguchi, Daisuke Aoki, Hiroyuki Nomura, Hiroyuki Yoshikawa, Toyomi Satoh, Toshiko Jobo, Hiroyuki Fujiwara, Yuji Takei, Seiryu Kamoi, Yasuhisa Terao, Seiji Isonishi, Pathology-oriented treatment strategy of malignant ovarian tumor in pregnant women: analysis of 41 cases in Japan, International Journal of Clinical Oncology, 2014, 19, 6, 1074

    CrossRef

  7. 7
    Ting-Ting Gong, Qi-Jun Wu, Emily Vogtmann, Bei Lin, Yong-Lai Wang, Age at menarche and risk of ovarian cancer: A meta-analysis of epidemiological studies, International Journal of Cancer, 2013, 132, 12
  8. 8
    C. Siristatidis, T. N. Sergentanis, P. Kanavidis, M. Trivella, M. Sotiraki, I. Mavromatis, T. Psaltopoulou, A. Skalkidou, E. T. Petridou, Controlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer--a systematic review and meta-analysis, Human Reproduction Update, 2013, 19, 2, 105

    CrossRef

  9. 9
    Susanne Schüler, Marvin Ponnath, Jörg Engel, Olaf Ortmann, Ovarian epithelial tumors and reproductive factors: a systematic review, Archives of Gynecology and Obstetrics, 2013, 287, 6, 1187

    CrossRef

  10. 10
    Nicolas Wentzensen, Britton Trabert, Joellen Schildkraut, Women and Health, 2013,

    CrossRef

  11. 11
    S Wilailak, C Vipupinyo, V Suraseranivong, K Chotivanich, C Kietpeerakool, Y Tanapat, S Therasakvichya, S Hamontri, V Linasmita, S Bunyapipat, S Chindavijak, K Ittiwisavakul, N Khemapech, P Suekwattana, D Thanapprapasr, P Lumbiganon, Depot medroxyprogesterone acetate and epithelial ovarian cancer: a multicentre case–control study, BJOG: An International Journal of Obstetrics & Gynaecology, 2012, 119, 6
  12. 12
    Maria Koutsaki, Apostolos Zaravinos, Demetrios A. Spandidos, Modern Trends into the Epidemiology and Screening of Ovarian Cancer. Genetic Substrate of the Sporadic Form, Pathology & Oncology Research, 2012, 18, 2, 135

    CrossRef

  13. 13
    B Trabert, N Wentzensen, H P Yang, M E Sherman, A Hollenbeck, K N Danforth, Y Park, L A Brinton, Ovarian cancer and menopausal hormone therapy in the NIH-AARP diet and health study, British Journal of Cancer, 2012, 107, 7, 1181

    CrossRef

  14. 14
    Anita Smith, Rodney P. Rocconi, Michael A. Finan, Signs of Aging or the Vague Symptoms of Ovarian Cancer?, Oncology Nursing Forum, 2012, 39, 2, E150

    CrossRef

  15. 15
    Annette S. Neill, Christina M. Nagle, Amanda B. Spurdle, Penelope M. Webb, Use of talcum powder and endometrial cancer risk, Cancer Causes & Control, 2012, 23, 3, 513

    CrossRef

  16. 16
    Allison F. Vitonis, Linda Titus-Ernstoff, Daniel W. Cramer, Assessing Ovarian Cancer Risk When Considering Elective Oophorectomy at the Time of Hysterectomy, Obstetrics & Gynecology, 2011, 117, 5, 1042

    CrossRef

  17. 17
    Roberta B. Ness, Rhiannon C. Dodge, Robert P. Edwards, Julie A. Baker, Kirsten B. Moysich, Contraception Methods, Beyond Oral Contraceptives and Tubal Ligation, and Risk of Ovarian Cancer, Annals of Epidemiology, 2011, 21, 3, 188

    CrossRef

  18. 18
    Tracy A. O'Mara, Christina M. Nagle, Jyotsna Batra, Mary-Anne Kedda, Judith A. Clements, Amanda B. Spurdle, Kallikrein-Related Peptidase 3 (KLK3/PSA) Single Nucleotide Polymorphisms and Ovarian Cancer Survival, Twin Research and Human Genetics, 2011, 14, 04, 323

    CrossRef

  19. 19
    K K Tsilidis, N E Allen, T J Key, L Dossus, A Lukanova, K Bakken, E Lund, A Fournier, K Overvad, L Hansen, A Tjønneland, V Fedirko, S Rinaldi, I Romieu, F Clavel-Chapelon, P Engel, R Kaaks, M Schütze, A Steffen, C Bamia, A Trichopoulou, D Zylis, G Masala, V Pala, R Galasso, R Tumino, C Sacerdote, H B Bueno-de-Mesquita, F J B van Duijnhoven, M G M Braem, N C Onland-Moret, I T Gram, L Rodríguez, N Travier, M-J Sánchez, J M Huerta, E Ardanaz, N Larrañaga, K Jirström, J Manjer, A Idahl, N Ohlson, K-T Khaw, N Wareham, T Mouw, T Norat, E Riboli, Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition, British Journal of Cancer, 2011, 105, 9, 1436

    CrossRef

  20. 20
    Hui-Wen Lin, Ying-Yueh Tu, Shiyng Yu Lin, Wei-Ju Su, Wei Li Lin, Wei Zer Lin, Shen-Chi Wu, Yuen-Liang Lai, Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study, The Lancet Oncology, 2011, 12, 9, 900

    CrossRef

  21. 21
    D. Cibula, M. Widschwendter, O. Majek, L. Dusek, Tubal ligation and the risk of ovarian cancer: review and meta-analysis, Human Reproduction Update, 2011, 17, 1, 55

    CrossRef

  22. 22
    Linda Titus-Ernstoff, Judy R. Rees, Kathryn L. Terry, Daniel W. Cramer, Breast-feeding the last born child and risk of ovarian cancer, Cancer Causes & Control, 2010, 21, 2, 201

    CrossRef

  23. 23
    Thanasak Sueblinvong, Michael E. Carney, Current Understanding of Risk Factors for Ovarian Cancer, Current Treatment Options in Oncology, 2009, 10, 1-2, 67

    CrossRef

  24. 24
    Marie-Louise B. Dick, Vic Siskind, David M. Purdie, Adèle C. Green, Incomplete pregnancy and risk of ovarian cancer: results from two Australian case–control studies and systematic review, Cancer Causes & Control, 2009, 20, 9, 1571

    CrossRef

  25. 25
    Y.F. LI, W. HU, S.Q. FU, J.D. LI, J.H. LIU, J.J. KAVANAGH, Aromatase inhibitors in ovarian cancer: is there a role?, International Journal of Gynecological Cancer, 2008, 18, 4
  26. 26
    Inkyung Baik, Mats Lambe, Qin Liu, Lucy Chie, Sven Cnattingius, Lorelei A. Mucci, Tomas Riman, Anders Ekbom, Hans-Olov Adami, Chung-Cheng Hsieh, Birth spacing and maternal risk of invasive epithelial ovarian cancer in a Swedish nationwide cohort, Cancer Causes & Control, 2008, 19, 10, 1131

    CrossRef

  27. 27
    Shelley S. Tworoger, Dorota M. Gertig, Margaret A. Gates, Jonathan L. Hecht, Susan E. Hankinson, Caffeine, alcohol, smoking, and the risk of incident epithelial ovarian cancer, Cancer, 2008, 112, 5
  28. 28
    Bo Zhou, Qingmin Sun, Rihong Cong, Haijuan Gu, Naping Tang, Li Yang, Bin Wang, Hormone replacement therapy and ovarian cancer risk: A meta-analysis, Gynecologic Oncology, 2008, 108, 3, 641

    CrossRef

  29. 29
    Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23 257 women with ovarian cancer and 87 303 controls, The Lancet, 2008, 371, 9609, 303

    CrossRef

  30. 30
    Joshua E. Muscat, Michael S. Huncharek, Perineal talc use and ovarian cancer: a critical review, European Journal of Cancer Prevention, 2008, 17, 2, 139

    CrossRef

  31. 31
    Fariba Salehi, Lesley Dunfield, Karen P. Phillips, Daniel Krewski, Barbara C. Vanderhyden, Risk Factors for Ovarian Cancer: An Overview with Emphasis on Hormonal Factors, Journal of Toxicology and Environmental Health, Part B, 2008, 11, 3-4, 301

    CrossRef

  32. 32
    C.M. NAGLE, C.J. BAIN, A.C. GREEN, P.M. WEBB, The influence of reproductive and hormonal factors on ovarian cancer survival, International Journal of Gynecological Cancer, 2008, 18, 3
  33. 33
    C.-Y. YANG, H.-W. KUO, H.-F. CHIU, Age at first birth, parity, and risk of death from ovarian cancer in Taiwan: a country of low incidence of ovarian cancer, International Journal of Gynecological Cancer, 2007, 17, 1
    Direct Link:
  34. 34
    C Featherstone, A Colley, K Tucker, J Kirk, M B Barton, Estimating the referral rate for cancer genetic assessment from a systematic review of the evidence, British Journal of Cancer, 2007, 96, 2, 391

    CrossRef

  35. 35
    Christina M. Nagle, Georgia Chenevix-Trench, Penelope M. Webb, Amanda B. Spurdle, Ovarian cancer survival and polymorphisms in hormone and DNA repair pathway genes, Cancer Letters, 2007, 251, 1, 96

    CrossRef

  36. 36
    Sharon E. Johnatty, Christina M. Nagle, Amanda B. Spurdle, Xiaoqing Chen, Penelope M. Webb, Georgia Chenevix-Trench, The MnSOD Val9Ala polymorphism, dietary antioxidant intake, risk and survival in ovarian cancer (Australia), Gynecologic Oncology, 2007, 107, 3, 388

    CrossRef

  37. 37
    Christina M. Nagle, Georgia Chenevix-Trench, Amanda B. Spurdle, Penelope M. Webb, The role of glutathione-S-transferase polymorphisms in ovarian cancer survival, European Journal of Cancer, 2007, 43, 2, 283

    CrossRef

  38. 38
    Michael Huncharek, Joshua Muscat, Adedayo Onitilo, Bruce Kupelnick, Use of cosmetic talc on contraceptive diaphragms and risk of ovarian cancer: a meta-analysis of nine observational studies, European Journal of Cancer Prevention, 2007, 16, 5, 422

    CrossRef

  39. 39
    Julia B. Greer, Francesmary Modugno, Roberta B. Ness, Glenn O. Allen, Anthropometry and the risk of epithelial ovarian cancer, Cancer, 2006, 106, 10
  40. 40
    Robert Baan, Kurt Straif, Yann Grosse, Béatrice Secretan, Fatiha El Ghissassi, Vincent Cogliano, Carcinogenicity of carbon black, titanium dioxide, and talc, The Lancet Oncology, 2006, 7, 4, 295

    CrossRef

  41. 41
    Shona M. Tormey, Carmel M. Malone, Edna W. McDermott, Niall J. O'Higgins, Arnold D.K. Hill, Current Status of Combined Hormone Replacement Therapy in Clinical Practice, Clinical Breast Cancer, 2006, 6, S51

    CrossRef

  42. 42
    Susan J. Jordan, David C. Whiteman, David M. Purdie, Adèle C. Green, Penelope M. Webb, Does smoking increase risk of ovarian cancer? A systematic review, Gynecologic Oncology, 2006, 103, 3, 1122

    CrossRef

  43. 43
    Joanne Kotsopoulos, Jan Lubinski, Susan L. Neuhausen, Henry T. Lynch, Barry Rosen, Peter Ainsworth, Pal Moller, Parviz Ghadirian, Claudine Isaacs, Beth Karlan, Ping Sun, Steven A. Narod, Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers, Gynecologic Oncology, 2006, 100, 1, 83

    CrossRef

  44. 44
    Jean S. Fleming, Clare R. Beaugié, Izhak Haviv, Georgia Chenevix-Trench, Olivia L. Tan, Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: Revisiting old hypotheses, Molecular and Cellular Endocrinology, 2006, 247, 1-2, 4

    CrossRef

  45. 45
    Carlo La Vecchia, Oral contraceptives and ovarian cancer: an update, 1998???2004, European Journal of Cancer Prevention, 2006, 15, 2, 117

    CrossRef

  46. 46
    Neeraja B. Peterson, Amy Trentham-Dietz, Polly A. Newcomb, Zhi Chen, Tebeb Gebretsadik, John M. Hampton, Meir J. Stampfer, Walter C. Willett, Kathleen M. Egan, Relation of Anthropometric Measurements to Ovarian Cancer Risk in a Population-based Case–control Study (United States), Cancer Causes & Control, 2006, 17, 4, 459

    CrossRef

  47. 47
    Livia Kelemen, Michael James, Amanda Spurdle, Ian Campbell, Jenny Chang-Claude, David Peel, Hoda Anton-Culver, Andrew Berchuck, Joellen Schildkraut, Alice Whittemore, Valerie McGurie, Richard A. DiCioccio, David Duffy, Georgia Chenevix-Trench, BRAF polymorphisms and the risk of ovarian cancer of low malignant potential, Gynecologic Oncology, 2005, 97, 3, 807

    CrossRef

  48. 48
    Francesca Chiaffarino, Claudio Pelucchi, Eva Negri, Fabio Parazzini, Silvia Franceschi, Renato Talamini, Maurizio Montella, Valerio Ramazzotti, Carlo La Vecchia, Breastfeeding and the risk of epithelial ovarian cancer in an Italian population, Gynecologic Oncology, 2005, 98, 2, 304

    CrossRef

  49. 49
    A.E. Guppy, P.D. Nathan, G.J.S. Rustin, Epithelial Ovarian Cancer: A Review of Current Management, Clinical Oncology, 2005, 17, 6, 399

    CrossRef

  50. 50
    V. Loizzi, G. Cormio, M. Vicino, N. Fattizzi, S. Bettocchi, L. Selvaggi, Hormone replacement therapy on ovarian and uterine cancer risk and cancer survivors: how shall we do no harm?, International Journal of Gynecological Cancer, 2005, 15, 3
  51. 51
    Bernard A. Rosner, Graham A. Colditz, Penny M. Webb, Susan E. Hankinson, Mathematical Models of Ovarian Cancer Incidence, Epidemiology, 2005, 16, 4, 508

    CrossRef

  52. 52
    Livia Kelemen, Amanda B. Spurdle, David M. Purdie, Dorota Gertig, Georgia Chenevix-Trench, RAD52 Y415X truncation polymorphism and epithelial ovarian cancer risk in Australian women, Cancer Letters, 2005, 218, 2, 191

    CrossRef

  53. 53
    G. L. Gierach, F. Modugno, R. B. Ness, Relations of Gestational Length and Timing and Type of Incomplete Pregnancy to Ovarian Cancer Risk, American Journal of Epidemiology, 2005, 161, 5, 452

    CrossRef

  54. 54
    Yoshimitsu Niwa, Hiroshi Yatsuya, Koji Tamakoshi, Kazuko Nishio, Takaaki Kondo, Yingsong Lin, Sadao Suzuki, Kenji Wakai, Shinkan Tokudome, Akio Yamamoto, Nobuyuki Hamajima, Hideaki Toyoshima, Akiko Tamakoshi, Relationship between body mass index and the risk of ovarian cancer in the Japanese population: Findings from the Japanese Collaborate Cohort (JACC) study, Journal of Obstetrics and Gynaecology Research, 2005, 31, 5
  55. 55
    Susan C. Modesitt, John R. van Nagell, The Impact of Obesity on the Incidence and Treatment of Gynecologic Cancers: A Review, Obstetrical & Gynecological Survey, 2005, 60, 10, 683

    CrossRef

  56. 56
    Sonya Kashyap, David Moher, Michael Fung Kee Fung, Zev Rosenwaks, Assisted Reproductive Technology and the Incidence of Ovarian Cancer: A Meta-Analysis, Obstetrics & Gynecology, 2004, 103, 4, 785

    CrossRef

  57. 57
    G. C. Zografos, M. Panou, N. Panou, Common risk factors of breast and ovarian cancer: recent view, International Journal of Gynecological Cancer, 2004, 14, 5
  58. 58
    Séverine Cunat, Pascale Hoffmann, Pascal Pujol, Estrogens and epithelial ovarian cancer, Gynecologic Oncology, 2004, 94, 1, 25

    CrossRef

  59. 59
    Alessandra Tavani, Cristina Bosetti, Luigino Dal Maso, Laura Giordano, Silvia Franceschi, Carlo La Vecchia, Influence of selected hormonal and lifestyle factors on familial propensity to ovarian cancer, Gynecologic Oncology, 2004, 92, 3, 922

    CrossRef

  60. 60
    AA Odukogbe, CA Adebamowo, B Ola, O Olayemi, A Oladokun, IF Adewole, OA Omigbodun, CO Aimakhu, MA Okunlola, O Fakulujo, FA Oluyemi, Ovarian cancer in Ibadan: characteristics and management, Journal of Obstetrics & Gynaecology, 2004, 24, 3, 294

    CrossRef

  61. 61
    Tomas Riman, Staffan Nilsson, Ingemar R. Persson, Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies, Acta Obstetricia et Gynecologica Scandinavica, 2004, 83, 9
  62. 62
    Pamela T Soliman, Brian M Slomovitz, Russell R Broaddus, Charlotte C Sun, Jonathan C Oh, Patricia J Eifel, David M Gershenson, Karen H Lu, Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases, Gynecologic Oncology, 2004, 94, 2, 456

    CrossRef

  63. 63
    Roberta B. Ness, Endometriosis and ovarian cancer: Thoughts on shared pathophysiology, American Journal of Obstetrics and Gynecology, 2003, 189, 1, 280

    CrossRef

  64. 64
    Shelly F Greenfield, Sumita G Manwani, Jessica E Nargiso, Epidemiology of substance use disorders in women, Obstetrics and Gynecology Clinics of North America, 2003, 30, 3, 413

    CrossRef

  65. 65
    A. Engeland, S. Tretli, T. Bjorge, Height, Body Mass Index, and Ovarian Cancer: A Follow-Up of 1.1 Million Norwegian Women, JNCI Journal of the National Cancer Institute, 2003, 95, 16, 1244

    CrossRef

  66. 66
    Crystal L. Laurvick, James B. Semmens, C. D'Arcy J. Holman, Yee C. Leung, Ovarian cancer in Western Australia (1982–98): incidence, mortality and survival, Australian and New Zealand Journal of Public Health, 2003, 27, 6
  67. 67
    David M. Purdie, Penelope M. Webb, Victor Siskind, Christopher J. Bain, Adèle C. Green, The Different Etiologies of Mucinous and Nonmucinous Epithelial Ovarian Cancers, Gynecologic Oncology, 2003, 88, 1, S145

    CrossRef

  68. 68
    Amanda B Spurdle, David M Purdie, Xiaoqing Chen, Georgia Chenevix-Trench, The prohibitin 3′ untranslated region polymorphism is not associated with risk of ovarian cancer, Gynecologic Oncology, 2003, 90, 1, 145

    CrossRef

  69. 69
    L Dal Maso, S Franceschi, E Negri, E Conti, M Montella, S Vaccarella, V Canzonieri, F Parazzini, C La Vecchia, Body size indices at different ages and epithelial ovarian cancer risk, European Journal of Cancer, 2002, 38, 13, 1769

    CrossRef

  70. 70
    Alfred P. Wehner, Cosmetic Talc Should Not Be Listed as a Carcinogen: Comments on NTP's Deliberations to List Talc as a Carcinogen, Regulatory Toxicology and Pharmacology, 2002, 36, 1, 40

    CrossRef

  71. 71
    Victor Siskind, David Purdie, David Whiteman, Adele Green, Epithelial Ovarian Carcinoma and Fertility of Parents, Epidemiology, 2002, 13, 5, 609

    CrossRef

  72. 72
    Harvey A. Risch, Hormone Replacement Therapy and the Risk of Ovarian Cancer, Gynecologic Oncology, 2002, 86, 2, 115

    CrossRef

  73. 73
    Hermann P.G Schneider, HRT and cancer risks, Maturitas, 2002, 43, 35

    CrossRef

  74. 74
    Amanda B. Spurdle, Bryan Goodwin, Ecushla Hodgson, John L. Hopper, Xiaoqing Chen, David M. Purdie, Margaret R. E. McCredie, Graham G. Giles, Georgia Chenevix-Trench, Christopher Liddle, The CYP3A4*1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancer, Pharmacogenetics, 2002, 12, 5, 355

    CrossRef

  75. 75
    R J Edmondson, J M Monaghan, B R Davies, The human ovarian surface epithelium is an androgen responsive tissue, British Journal of Cancer, 2002, 86, 6, 879

    CrossRef

  76. 76
    Jacqueline Royar, Heiko Becher, Jenny Chang-Claude, Low-dose oral contraceptives: Protective effect on ovarian cancer risk, International Journal of Cancer, 2001, 95, 6
  77. 77
    Carlo La Vecchia, Louise A Brinton, Anne McTiernan, Menopause, hormone replacement therapy and cancer, Maturitas, 2001, 39, 2, 97

    CrossRef

  78. 78
    Roberta B. Ness, Jeane Ann Grisso, Ron Vergona, Jennifer Klapper, Mark Morgan, James E. Wheeler, Oral Contraceptives, Other Methods of Contraception, and Risk Reduction for Ovarian Cancer, Epidemiology, 2001, 12, 3, 307

    CrossRef

  79. 79
    Tomas Riman, Paul W. Dickman, Staffan Nilsson, Nestor Correia, Hans Nordlinder, Cecilia M. Magnusson, Ingemar R. Persson, Risk Factors for Epithelial Borderline Ovarian Tumors: Results of a Swedish Case–Control Study, Gynecologic Oncology, 2001, 83, 3, 575

    CrossRef

  80. 80
    R. J. Edmondson, J. M. Monaghan, The epidemiology of ovarian cancer, International Journal of Gynecological Cancer, 2001, 11, 6
  81. 81
    Amanda B. Spurdle, David M. Purdie, Penelope M. Webb, Xiaoqing Chen, Adele Green, Georgia Chenevix-Trench, The microsomal epoxide hydrolase Tyr113His polymorphism: Association with risk of ovarian cancer, Molecular Carcinogenesis, 2001, 30, 1
  82. 82
    Steven S. Coughlin, AnnGene Giustozzi, S.Jay Smith, Nancy C. Lee, A meta-analysis of estrogen replacement therapy and risk of epithelial ovarian cancer, Journal of Clinical Epidemiology, 2000, 53, 4, 367

    CrossRef

  83. 83
    Amanda B. Spurdle, Penelope M. Webb, Xiaoqing Chen, Nicholas G. Martin, Graham G. Giles, John L. Hopper, Georgia Chenevix-Trench, Androgen receptor exon 1 cag repeat length and risk of ovarian cancer, International Journal of Cancer, 2000, 87, 5
  84. 84
    Victor Siskind, Adéle Green, Chris Bain, David Purdie, Beyond Ovulation: Oral Contraceptives and Epithelial Ovarian Cancer, Epidemiology, 2000, 11, 2, 106

    CrossRef

  85. 85
    Petra M. Kuhnert, Kim-Anh Do, Rod McClure, Combining non-parametric models with logistic regression: an application to motor vehicle injury data, Computational Statistics & Data Analysis, 2000, 34, 3, 371

    CrossRef

  86. 86
    Amanda B. Spurdle, Xiaoqing Chen, Mohammed Abbazadegan, Nicholas Martin, Soo-Keat Khoo, Terry Hurst, Bruce Ward, Penelope M. Webb, Georgia Chenevix-Trench, CYP17 promotor polymorphism and ovarian cancer risk, International Journal of Cancer, 2000, 86, 3
  87. 87
    Victor Siskind, Judith P. Kelly, David W. Kaufman, Estimating risks for matching factors in case-control studies, Journal of Clinical Epidemiology, 2000, 53, 3, 251

    CrossRef

  88. 88
    Christine H. Holschneider, Jonathan S. Berek, Ovarian cancer: Epidemiology, biology, and prognostic factors, Seminars in Surgical Oncology, 2000, 19, 1
  89. 89
    John Whysner, Melissa Mohan, Perineal application of talc and cornstarch powders: Evaluation of ovarian cancer risk, American Journal of Obstetrics and Gynecology, 2000, 182, 3, 720

    CrossRef

  90. 90
    D. M. Gertig, D. J. Hunter, D. W. Cramer, G. A. Colditz, F. E. Speizer, W. C. Willett, S. E. Hankinson, Prospective Study of Talc Use and Ovarian Cancer, JNCI Journal of the National Cancer Institute, 2000, 92, 3, 249

    CrossRef

  91. 91
    Stefano Greggi, Fabio Parazzini, Maria Piera Paratore, Liliane Chatenoud, Francesco Legge, Salvatore Mancuso, Carlo La Vecchia, Risk Factors for Ovarian Cancer in Central Italy, Gynecologic Oncology, 2000, 79, 1, 50

    CrossRef

  92. 92
    Shigemi Sato, Yoshihito Yokoyama, Tomomi Sakamoto, Masayuki Futagami, Yoshiharu Saito, Usefulness of mass screening for ovarian carcinoma using transvaginal ultrasonography, Cancer, 2000, 89, 3
  93. 93
    Phyllis A. Wingo, Anne McTiernan, Women and Health, 2000,

    CrossRef

  94. 94
    Franco Guidozzi, Alexandros Daponte, Estrogen replacement therapy for ovarian carcinoma survivors, Cancer, 1999, 86, 6
  95. 95
    R. B. Ness, C. Cottreau, Possible Role of Ovarian Epithelial Inflammation in Ovarian Cancer, JNCI Journal of the National Cancer Institute, 1999, 91, 17, 1459

    CrossRef

  96. 96
    John F. Stratton, Paul Pharoah, Steven K. Smith, Doug Easton, Bruce A. J. Ponder, A systematic review and meta-analysis of family history and risk of ovarian cancer, BJOG: An International Journal of Obstetrics & Gynaecology, 1998, 105, 5
  97. 97
    Mitsuru Mori, Takashi Nishida, Toru Sugiyama, Kan Komai, Michiaki Yakushiji, Koichi Fukuda, Toshimitsu Tanaka, Masatoshi Yokoyama, Hajime Sugimori, Anthropometric and Other Risk Factors for Ovarian Cancer in a Case-Control Study, Japanese Journal of Cancer Research, 1998, 89, 3
  98. 98
    Tomas Riman, Ingemar Persson, Staffan Nilsson, Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence, Clinical Endocrinology, 1998, 49, 6
  99. 99
    H. A. Risch, Hormonal Etiology of Epithelial Ovarian Cancer, With a Hypothesis Concerning the Role of Androgens and Progesterone, JNCI Journal of the National Cancer Institute, 1998, 90, 23, 1774

    CrossRef

  100. 100
    P. M. Webb, D. M. Purdie, M. C. Cummings, M. D. Walsh, A. Green, G. Chenevix-Trench, Relationship Between Number of Ovulatory Cycles and Accumulation of Mutant p53 in Epithelial Ovarian Cancer, JNCI Journal of the National Cancer Institute, 1998, 90, 22, 1729

    CrossRef

  101. 101
    G. Chenevix-Trench, T. Coombs, J. Kerr, D. Purdie, A. Green, M. C. Cummings, Fertility and Incidence of KRAS2 Mutations in Borderline Ovarian Adenocarcinomas, JNCI Journal of the National Cancer Institute, 1997, 89, 12, 890

    CrossRef

  102. 102
    Anne Loft, Øjvind Lidegaard, Ann Tabor, Incidence of ovarian cancer after hysterectomy: a nationwide controlled follow up, BJOG: An International Journal of Obstetrics & Gynaecology, 1997, 104, 11
  103. 103
    C. Frost, M.P. Coleman, Obesity and ovarian cancer, European Journal of Cancer, 1997, 33, 10, 1529

    CrossRef

  104. 104
    Adèle Green, David Purdie, Christopher Bain, Victor Siskind, Peter Russell, Michael Quinn, Bruce Ward, Tubal sterilisation, hysterectomy and decreased risk of ovarian cancer, International Journal of Cancer, 1997, 71, 6
  105. 105
    Adele Green, David Purdie, Lynn Green, Marie–Louise Dick, Christopher Bain, Victor Siskind, Validity of self–reported hysterectomy and tubal sterilisation, Australian and New Zealand Journal of Public Health, 1997, 21, 3
  106. 106
    Adele Green, David Purdie, Lynn Green, Marie–Louise Dick, Christopher Bain, Victor Siskind, Validity of self–reported hysterectomy and tubal sterilisation, Australian and New Zealand Journal of Public Health, 1977, 21, 3, 337

    CrossRef

  107. 107
    Ivana Rizzuto, Renee F Behrens, Lesley A Smith, Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility, The Cochrane Library,